Septerna (SEPN) Receivables - Net (2023 - 2026)

Septerna's quarterly Receivables - Net came in at $10.8 million in Q1 2026, up 4236.8% year-on-year from $250000.0 in Q1 2025, and up 4.69% quarter-over-quarter from $10.4 million in Q4 2025.

Septerna has reported Receivables - Net for 4 years, with the latest figure at $10.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Receivables - Net rose 4236.8% year-over-year to $10.8 million; the trailing twelve-month figure through Mar 2026 stood at $10.8 million (up 4236.8% YoY), and the FY2025 full-year result was $10.4 million, up 5956.14% from the prior year.
  • Receivables - Net for Q1 2026 stood at $10.8 million, up from $10.4 million in the prior quarter.
  • The five-year high for Receivables - Net was $22.6 million in Q4 2023, with the low at $151000.0 in Q2 2025.
  • Average Receivables - Net over 4 years is $6.7 million, with a median of $4.4 million recorded in 2025.
  • Year-over-year, Receivables - Net slumped 99.24% in 2024 and soared 5956.14% in 2025.
  • Tracing SEPN's Receivables - Net over 4 years: stood at $22.6 million in 2023, then tumbled by 99.24% to $171000.0 in 2024, then soared by 5956.14% to $10.4 million in 2025, then advanced by 4.69% to $10.8 million in 2026.
  • The last three Receivables - Net figures came in at $10.8 million (Q1 2026), $10.4 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Septerna 1.34 Bn 1.34 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.84 Mn
Mar 31, 2026 10.84 Mn
Dec 31, 2025 10.36 Mn
Dec 31, 2025 10.36 Mn
Sep 30, 2025 8.65 Mn
Sep 30, 2025 8.65 Mn
Jun 30, 2025 151,000.00
Jun 30, 2025 151,000.00
Mar 31, 2025 250,000.00
Mar 31, 2025 250,000.00
Dec 31, 2024 171,000.00
Dec 31, 2024 171,000.00
Sep 30, 2024 210,000.00
Sep 30, 2024 210,000.00
Dec 31, 2023 22.63 Mn
Dec 31, 2023 22.63 Mn